Edition:
India

People: Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

2.08USD
20 Sep 2019
Change (% chg)

-- (--)
Prev Close
$2.08
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
61,093
52-wk High
$7.39
52-wk Low
$0.81

Guse, Kyle 

Mr. Kyle Guse Esq., CPA., is Chief Financial Officer, General Counsel, Secretary of Atossa Genetics Inc., since January 4, 2013. His experience includes more than 25 years of counseling life sciences and other rapid growth companies through all aspects of finance, corporate governance, securities laws and commercialization. Mr. Guse has practiced law at several of the largest international law firms, including from January 2012 through January 2013 as a partner at Baker Botts LLP and, prior to that, from October 2007 to January 2012, as a partner at McDermott Will & Emery LLP. Before working at McDermott Will & Emery, Mr. Guse previously served as a partner at Heller Ehrman LLP. Mr. Guse began his career as an accountant at Deloitte & Touche and he is a licensed Certified Public Accountant and member of the Bar in the State of California. Mr. Guse earned a B.S. in business administration and an M.B.A. from California State University, Sacramento, and a J.D. from Santa Clara University School of Law.

Basic Compensation

Total Annual Compensation, USD 364,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 371,719
Fiscal Year Total, USD 735,719

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --